Literature DB >> 10677302

Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42.

M Brockington1, C A Sewry, R Herrmann, I Naom, A Dearlove, M Rhodes, H Topaloglu, V Dubowitz, T Voit, F Muntoni.   

Abstract

We have previously reported an autosomal recessive form of congenital muscular dystrophy, characterized by proximal girdle weakness, generalized muscle hypertrophy, rigidity of the spine, and contractures of the tendo Achilles, in a consanguineous family from the United Arab Emirates. Early respiratory failure resulting from severe diaphragmatic involvement was present. Intellect and the results of brain imaging were normal. Serum creatine kinase levels were grossly elevated, and muscle-biopsy samples showed dystrophic changes. The expression of the laminin-alpha2 chain of merosin was reduced on several fibers, but linkage analysis excluded the LAMA2 locus on chromosome 6q22-23. Here, we report the results of genomewide linkage analysis of this family, by use of homozygosity mapping. In all four affected children, an identical homozygous region was identified on chromosome 1q42, spanning 6-15 cM between flanking markers D1S2860 and D1S2800. We have identified a second German family with two affected children having similar clinical and histopathological features; they are consistent with linkage to the same locus. The cumulative LOD score was 3.57 (straight theta=.00) at marker D1S213. This represents a novel locus for congenital muscular dystrophy. We suggest calling this disorder "CMD1B." The expression of three functional candidate genes in the CMD1B critical region was investigated, and no detectable changes in their level of expression were observed. The secondary reduction in laminin-alpha2 chain in these families suggests that the primary genetic defect resides in a gene coding for a protein involved in basal lamina assembly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677302      PMCID: PMC1288095          DOI: 10.1086/302775

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  31 in total

1.  Mutations in the laminin alpha2-chain gene in two children with early-onset muscular dystrophy.

Authors:  I Naom; M D'alessandro; C A Sewry; P Jardine; A Ferlini; T Moss; V Dubowitz; F Muntoni
Journal:  Brain       Date:  2000-01       Impact factor: 13.501

2.  Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy.

Authors:  K J Nowak; D Wattanasirichaigoon; H H Goebel; M Wilce; K Pelin; K Donner; R L Jacob; C Hübner; K Oexle; J R Anderson; C M Verity; K N North; S T Iannaccone; C R Müller; P Nürnberg; F Muntoni; C Sewry; I Hughes; R Sutphen; A G Lacson; K J Swoboda; J Vigneron; C Wallgren-Pettersson; A H Beggs; N G Laing
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

3.  Expression of laminin subunits in congenital muscular dystrophy.

Authors:  C A Sewry; J Philpot; D Mahony; L A Wilson; F Muntoni; V Dubowitz
Journal:  Neuromuscul Disord       Date:  1995-07       Impact factor: 4.296

4.  Abnormal localization of laminin subunits in muscular dystrophies.

Authors:  Y K Hayashi; E Engvall; E Arikawa-Hirasawa; K Goto; R Koga; I Nonaka; H Sugita; K Arahata
Journal:  J Neurol Sci       Date:  1993-10       Impact factor: 3.181

Review 5.  Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage.

Authors:  K P Campbell
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

6.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

7.  Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy.

Authors:  A Helbling-Leclerc; X Zhang; H Topaloglu; C Cruaud; F Tesson; J Weissenbach; F M Tomé; K Schwartz; M Fardeau; K Tryggvason
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

8.  Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33.

Authors:  T Toda; M Segawa; Y Nomura; I Nonaka; K Masuda; T Ishihara; M Sakai; I Tomita; Y Origuchi; M ] Suzuki M [corrected to Sakai
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

9.  Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping.

Authors:  D Hillaire; A Leclerc; S Fauré; H Topaloglu; N Chiannilkulchaï; P Guicheney; L Grinas; P Legos; J Philpot; T Evangelista
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

10.  Congenital muscular dystrophy with merosin deficiency.

Authors:  F M Tomé; T Evangelista; A Leclerc; Y Sunada; E Manole; B Estournet; A Barois; K P Campbell; M Fardeau
Journal:  C R Acad Sci III       Date:  1994-04
View more
  7 in total

Review 1.  Obscurin: a multitasking muscle giant.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch
Journal:  J Muscle Res Cell Motil       Date:  2005       Impact factor: 2.698

2.  Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.

Authors:  M Brockington; D J Blake; P Prandini; S C Brown; S Torelli; M A Benson; C P Ponting; B Estournet; N B Romero; E Mercuri; T Voit; C A Sewry; P Guicheney; F Muntoni
Journal:  Am J Hum Genet       Date:  2001-10-08       Impact factor: 11.025

3.  Localisation of merosin-positive congenital muscular dystrophy to chromosome 4p16.3.

Authors:  G S Sellick; C Longman; M Brockington; I Mahjneh; L Sagi; K Bushby; H Topaloğlu; F Muntoni; R S Houlston
Journal:  Hum Genet       Date:  2005-05-11       Impact factor: 4.132

4.  Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy.

Authors:  Ercan Demir; Patrizia Sabatelli; Valérie Allamand; Ana Ferreiro; Behzad Moghadaszadeh; Mohamed Makrelouf; Haluk Topaloglu; Bernard Echenne; Luciano Merlini; Pascale Guicheney
Journal:  Am J Hum Genet       Date:  2002-04-24       Impact factor: 11.025

5.  Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.

Authors:  Susan C Brown; Silvia Torelli; Martin Brockington; Yeliz Yuva; Cecilia Jimenez; Lucy Feng; Louise Anderson; Isabella Ugo; Stephan Kroger; Kate Bushby; Thomas Voit; Caroline Sewry; Francesco Muntoni
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

Review 6.  Genetic and Clinical Advances of Congenital Muscular Dystrophy.

Authors:  Xiao-Na Fu; Hui Xiong
Journal:  Chin Med J (Engl)       Date:  2017-11-05       Impact factor: 2.628

Review 7.  The role of defective glycosylation in congenital muscular dystrophy.

Authors:  Harry Schachter; Jiri Vajsar; Wenli Zhang
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.